Your browser doesn't support javascript.
loading
Midodrine, an Oral Alpha-1 Adrenoreceptor Agonist, Successfully Treated Refractory Congenital Chylous Pleural Effusion and Ascites in a Neonate.
Tamaoka, Satoshi; Osada, Asami; Kin, Takane; Arimitsu, Takeshi; Hida, Mariko.
Afiliación
  • Tamaoka S; Department of Pediatrics, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan. Electronic address: rainbow09tama21@yahoo.co.jp.
  • Osada A; Department of Pediatrics, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Kin T; Department of Pediatrics, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Arimitsu T; Department of Pediatrics, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
  • Hida M; Department of Pediatrics, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Chest ; 159(4): e189-e191, 2021 04.
Article en En | MEDLINE | ID: mdl-34022016
A trisomy 21 neonate presented with congenital chylous pleural effusion and ascites that was refractory to conventional pharmacotherapy. Midodrine, an oral alpha-1-adrenoreceptor agonist, achieved remission of chylous effusion without any adverse effects. To the best of our knowledge, this is the first neonatal case of successful management of congenital chylous pleural effusion and ascites with midodrine.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Derrame Pleural / Ascitis Quilosa / Quilotórax / Midodrina Tipo de estudio: Etiology_studies Límite: Adult / Female / Humans / Newborn / Pregnancy Idioma: En Revista: Chest Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Derrame Pleural / Ascitis Quilosa / Quilotórax / Midodrina Tipo de estudio: Etiology_studies Límite: Adult / Female / Humans / Newborn / Pregnancy Idioma: En Revista: Chest Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos